Goldman Sachs leads a $4.25 billion financing package to support Sycamore Partners' $12.5 billion acquisition of Walgreens Boots Alliance's UK pharmacy chain.
Target Information
Sycamore Partners is set to acquire Walgreens Boots Alliance's UK-based pharmacy chain for $12.5 billion. This acquisition is part of a broader strategy to enhance Sycamore’s presence in the consumer healthcare sector, capitalizing on the growing demand for pharmacy services in the UK.
Walgreens Boots Alliance has a well-established network of pharmacies and healthcare services in the UK, which positions it as a key player in the market. The deal aligns with the trends in healthcare where accessibility and convenience are becoming increasingly vital for consumers.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The UK's pharmacy market has shown resilience and growth potential despite recent economic challenges. With a significant shift towards health and wellness, consumers
Similar Deals
Bridgepoint Advisers Limited → mydentist
2025
Beacon Homecare Services Limited → Lifetime Homecare Limited
2025
Sycamore Partners
invested in
Walgreens Boots Alliance’s UK-based pharmacy chain
in 2025
in a Buyout deal
Disclosed details
Transaction Size: $12,500M